Journals / Journal of Neurological Sciences (Turkish) / 2010 / Cilt: 27 - Sayı: 3

Parkinson Hastalığı'nda presinaptik inhibisyon ve disinaptik resiprokal 1a inhibisyonu, dopaminerjik tedavinin etkisi

Presynaptic inhibition and disynaptic reciprocal 1a inhibition in Parkinson's disease, the effect of the dopaminergic treatment

Pages
292–301
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These findings indicate an abnormal supraspinal influence on the spinal cord in Parkinson's disease, and also the role of some dopa responsive neural mechanisms.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In recent years, increasing number of studies about the spinal cord pathology in Parkinson's disease had been conducted.
📊
Key Findings & Data:This study has been adressed to assess the presynaptic and disynaptic inhibition levels in Parkinson's disease, and the effect of dopaminergic treatment.Methods: Presynaptic inhibition and dysynaptic reciprocal 1a inhibition is investigated by double stimulation of the tibial nerve at the popliteal fossa and peroneal nerve at the fibular head in patients with Parkinson's disease and also in control subjects for the 1-100 ms conditioning test intervals.
💡
Conclusion & Impact:These findings indicate an abnormal supraspinal influence on the spinal cord in Parkinson's disease, and also the role of some dopa responsive neural mechanisms.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In recent years, increasing number of studies about the spinal cord pathology in Parkinson's disease had been conducted. H reflex investigation is an important choice in the studies dealing with neurophysiological and interneuronal alterations of the spinal cord. The effect of the dopaminergic treatment on the spinal interneuronal reflex pathways is a relatively less investigated issue. This study has been adressed to assess the presynaptic and disynaptic inhibition levels in Parkinson's disease, and the effect of dopaminergic treatment.Methods: Presynaptic inhibition and dysynaptic reciprocal 1a inhibition is investigated by double stimulation of the tibial nerve at the popliteal fossa and peroneal nerve at the fibular head in patients with Parkinson's disease and also in control subjects for the 1-100 ms conditioning test intervals. The amplitude changes of the test and the conditioned H reflex responses were calculated and compared in the affected and less affected sides in both before and under dopaminergic treatment.Results: Disynaptic and presynaptic inhibitions existed in all subjects. Disynaptic reciprocal 1a inhibition was shortened only at 2 ms conditioning interval. The conditioned and test H reflex ratio (Hc/Ht) for the 20 ms conditioning test interval (presynaptic inhibition) was significantly smaller in the affected side than the controls (p: 0.046). The percentages of the inhibitions for the 20-10-5-3-2 ms conditioning intervals significantly increased in the affected side under treatment when compared with the ones obtained in the pretreatment period (p: 0.031, 0.027, 0.014, 0.026, 0.037).Conclusion: Presynaptic inhibition was decreased and disynaptic inhibition duration was shortened in the affected side of the patients with Parkinson's disease, dopaminergic treatment caused significant increases in both periods of inhibition. These findings indicate an abnormal supraspinal influence on the spinal cord in Parkinson's disease, and also the role of some dopa responsive neural mechanisms.

Özet

Amaç: Son zamanlarda Parkinson Hastalığında spinal kord patolojisi ile ilgili çalışmalara daha fazla rastlanmaktadır. H refleks incelemesi spinal kordaki nörofizyolojik ve internörinal değişiklikleri inceleyen çalışmalarda önemli bir seçenektir. Dopaminerjik tedavinin spinal internöronal refleks yollarındaki etkisi daha az araştırılmış bir konudur. Bu çalışma Parkinson Hastalığında presinaptik ve disinaptik inhibisyon düzeylerini, dopaminerjik tedavinin etkisini incelemek üzere planlanmıştır.Metod: Presinaptik inhibisyon ve disinaptik resiprokal 1a inhibisyonu Parkinson hastalarında ve normal kontrollerde 1-100 ms intervallerle peroneal sinirin ve tibial sinirin ikili uyarımı ile araştırıldı. Test ve şartlanmış H refleks yanıt amplitüd değişiklikleri hesaplandı. Dopaminerjik tedavi öncesi ve sonrası etkilenen ve daha az etkilenen taraflarda karşılaştırıldı.Bulgular: Disinaptik ve presinaptik inhibisyon tüm deneklerde mevcuttu. Disinaptik resiprokal 1 a inhibisyonu etkilenen tarafta daha kısa süreliydi ve sadece 2 ms'lik intervalde vardı. 20 ms'lik interval için şartlanmış ve test H refleks oranı (presinaptik inhibisyon) etkilenen tarafta kontrollere göre anlamlı düşük bulundu (p: 0.046). 20-10-5-3-2 ms'lik intervallerdeki inhibisyon oranları tedavi sonrası etkilenen tarafta tedavi öncesine göre anlamlı artmıştı (p: 0.031, 0.027,0.014, 0.026, 0.037).Sonuç: Parkinson hastalığında tutulan tarafta presinaptik inhibisyon azalmış, disinaptik inhibisyon süresi kısalmış bulunmuştur. Dopaminerjik tedavi, her iki inhibisyon periyodunda anlamlı artışa neden olmuştur. Bu bulgular Parkinson hastalığında supraspinal etkilerde anormallik varlığını ve ayrıca bazı dopaya cevaplı nöral mekanizmaların rolünü düşündürmüştür.

🔖

Cite This Article

YILDIZ, N., TURKOGLU, S. A., ALTUNRENDE, B., YILDIZ, S. K. (2022). Parkinson Hastalığı'nda presinaptik inhibisyon ve disinaptik resiprokal 1a inhibisyonu, dopaminerjik tedavinin etkisi. Journal of Neurological Sciences (Turkish), Cilt: 27 - Sayı: 3, 292–301. https://ajindex.com/articles/565383

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Bathien N, Rondot P. Reciprocal continuous inhibition in rigidity of Parkinsonism. J Neurol Neurosurg Psychiatry 1977;40:20-4
  2. Bergui M, Lopiano L, Paglia G, Quattrocolo G, Scarzella L, Bergamasco B. Stretch reflex of quadriceps femoris and its relation to rigidity in Parkinson's disease. Acta Neurol Scand 1992;86:226-9
  3. Bertolasi L, Priori A, Tinazzi M, Bertasi V, Rothwell JC Inhibitory action of forearm flexor muscle afferents on corticospinal outputs to antagonist muscles in humans. J Physiol 1998 Sep 15;511 ( Pt 3):947-56
  4. Bloch A, Probst a, Bissig H, Adams H, Tolnay M. Alpha-synuclein pathology and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 2006; 32(3): 284-95
  5. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003 Mar-Apr;24(2):197-211
  6. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K.Stages in the development of Parkinson's disease related pathology. Cell Tissue Res 2004 Oct; 318(1):121-34
  7. Butchart P, Farquhar R, Part NJ, Roberts RC. The effect of age and voluntary contraction on presynaptic inhibition of soleus muscle Ia afferent terminals in man. Exp Physiol 1993 Mar; 78(2):235-42
  8. Crone C, Hultborn H, Jespersen B, Nielsen J. Reciprocal Ia inhibition between ankle flexors and extensors in man. J Physiol 1987 Aug;389:163-85
  9. Crone C, Nielsen J. Central control of disynaptic reciprocal inhibition in humans. Acta Physiol Scand 1994 Dec;152(4):351-63 10) Day BL, Rothwell JC, Marsden CD. Transmission in the spinal reciprocal Ia inhibitory pathway preceding willed movements of the human wrist. Neurosci Lett 1983 Jun 30;37(3):245-50
  10. Day BL, Marsden CD, Obeso JA, Rothwell JC. Reciprocal inhibition between the muscles of the human forearm. J Physiol 1984 Apr;349:519-34
  11. Delwaide PJ, Pepin JL, de Noordhout MA. Short-latency autogenic inhibition in patients with parkinsonian rigidity. Ann Neurol 1991;30:83–89
  12. Dickson DW, Fujishiro H, DelleDonne A, Menke J, Ahmed Z, Klos KJ, Josephs KA, Frigerio R, Burnett M, Parisi JE, Ahlskog JE. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol 2008 Apr;115(4):437-44
  13. Fahn S, Elton RL, UPDRS program members. Unified Parkinson's disease rating scale. In Recent developments in Parkinson’s disease, Vol 2. Ed’s, Fahn S, Marsden CD, Goldstein M, Calne DB, Flor